Commentary · 28 Dec 2023
Conference abstractPublished 2019
Exploring needle-free transdermal immunization techniques for respiratory syncytial virus
Mercer University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Vaccine-enhanced respiratory disease has thwarted the attempts to develop a vaccine for Respiratory Syncytial Virus (RSV) using the inactivated form of the virus. As a result, there is a need for a safe and effective vaccine for RSV. Fusion protein is a one of the major proteins present on the surface of the virus, which can be integrated into a virus-like particle (VLP), yielding a highly immunogenic non- virulent F-VLP antigen. This study aims at using a needle free transdermal route of administration to exploit the rich population of Langerhans cells present in the epidermis and dermis. We have used microneedles (AdminPatch®) as well as Precise Laser Epidermal System (P.L.E.A.S.E), a minimally invasive ablative fractional (Er: YAG) laser for creating micro-channels to deliver the antigen.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Clinical Trials.
Commentary · 28 Dec 2023
Epidemiology and Global Impact of Dengue: Clinical Presentation and Disease Progression
Commentary · 28 Dec 2023
An Overview on Infectious Diseases: Its Global Impact and Challenges
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Clinical Trials
- SubjectPharmaceutical Sciences
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Ipshita Menon”

